300813 泰林生物
按盤價 
20.880 +2.830 (+15.679%)
20.880 +2.830 (+15.679%) | 2024/06 - 中期 人民幣(K¥) | 與去年末期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 8,000 | 100.00% | 4,000 | 0 | 0 | 0 |
| 投資性房地產 | 10,140 | -0.76% | 10,218 | 9,085 | 10,245 | 11,012 |
| 固定資產 | 262,740 | -0.78% | 264,794 | 102,583 | 95,916 | 85,251 |
| 在建工程 | 4,312 | 1.08% | 4,266 | 15,931 | 658 | 995 |
| 無形資產 | 10,998 | -2.42% | 11,271 | 11,817 | 12,368 | 11,598 |
| 商譽 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動資產 | 36,049 | -10.34% | 40,208 | 19,702 | 22,228 | 4,853 |
| 332,239 | -0.75% | 334,758 | 159,119 | 141,415 | 113,709 | |
流動資產 | ||||||
| 貨幣資金 | 300,038 | -24.42% | 396,983 | 577,154 | 302,461 | 322,154 |
| 應收賬款 | 44,912 | 24.47% | 36,082 | 42,578 | 38,483 | 17,874 |
| 存貨 | 158,909 | -1.02% | 160,550 | 111,201 | 122,447 | 63,194 |
| 其他流動資產 | 113,547 | 151.57% | 45,135 | 32,607 | 51,065 | 23,062 |
| 617,406 | -3.34% | 638,750 | 763,541 | 514,456 | 426,285 | |
流動負債 | ||||||
| 短期借款 | 8,250 | -- | 0 | 0 | 0 | 0 |
| 應付票據 | 0 | -100.00% | 202 | 1,532 | 2,197 | 2,943 |
| 應付帳款 | 15,431 | 6.03% | 14,553 | 12,746 | 14,476 | 11,161 |
| 其他流動負債 | 111,884 | -23.92% | 147,054 | 115,049 | 136,790 | 81,147 |
| 135,565 | -16.22% | 161,809 | 129,326 | 153,463 | 95,250 | |
| 流動資產淨值 | 481,841 | 1.03% | 476,941 | 634,215 | 360,993 | 331,034 |
| 資產總額減流動負債 | 814,080 | 0.29% | 811,699 | 793,334 | 502,408 | 444,743 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 0 | 0 | 0 |
| 應付債券 | 159,620 | 1.29% | 157,589 | 145,467 | 0 | 0 |
| 其他非流動負債 | 3,631 | -6.18% | 3,870 | 412 | 5,028 | 499 |
| 163,250 | 1.11% | 161,460 | 145,879 | 5,028 | 499 | |
總權益 | ||||||
| 實收股本 | 109,139 | 0.40% | 108,705 | 83,168 | 51,970 | 51,970 |
| 儲備項目 | 540,930 | 0.16% | 540,058 | 564,287 | 445,411 | 392,275 |
| 股東權益 | 650,069 | 0.20% | 648,763 | 647,455 | 497,381 | 444,245 |
| 非控股權益 | 760 | -48.51% | 1,476 | 0 | 0 | 0 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
